UnknownNot Applicable

ERG Protein Expression in Prostatic Adenocarcinoma and Its Clinicopathological Features

50 participantsStarted 2021-05-04

Plain-language summary

Evaluation the ERG expression in prostatic acinar adenocarcinoma and its association with clinicopathological features.

Age range50 Years – 90 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All cases diagnosed as prostatic acinar adenocarcinoma Exclusion Criteria: * Other types of prostatic cancer.

Evaluation the ERG expression in prostatic acinar adenocarcinoma

Timeframe: 3 days

NCT IDNCT04825691

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-30